Review: taking Adderall 30 and Lithium carbonate together


Summary

Drug interactions are reported among people who take Adderall 30 and Lithium carbonate together. This review analyzes the effectiveness and drug interactions between Adderall 30 and Lithium carbonate. It is created by eHealthMe based on reports of 230 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Adderall 30 and Lithium carbonate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Adderall 30

Adderall 30 has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Adderall 30 1,616 users)

Lithium Carbonate

Lithium carbonate has active ingredients of lithium carbonate. It is often used in bipolar disorder. (latest outcomes from Lithium carbonate 16,506 users)

On Aug, 25, 2016

230 people who take Adderall 30, Lithium Carbonate are studied.


Number of reports submitted per year:

Adderall 30 and Lithium carbonate drug interactions.

Drug effectiveness over time:

Adderall 30:
  • < 1 month: 60.0% - (3 of 5 people)
  • 1 - 6 months: 50.0% - (6 of 12 people)
  • 6 - 12 months: 63.0% - (7 of 11 people)
  • 1 - 2 years: 82.0% - (14 of 17 people)
  • 2 - 5 years: 68.0% - (11 of 16 people)
  • 5 - 10 years: 77.0% - (7 of 9 people)
  • 10+ years: 75.0% - (3 of 4 people)
  • not specified: 0.0% - (0 of 0 people)
Lithium Carbonate:
  • < 1 month: 25.0% - (3 of 12 people)
  • 1 - 6 months: 53.0% - (7 of 13 people)
  • 6 - 12 months: 14.0% - (1 of 7 people)
  • 1 - 2 years: 45.0% - (5 of 11 people)
  • 2 - 5 years: 50.0% - (4 of 8 people)
  • 5 - 10 years: 42.0% - (3 of 7 people)
  • 10+ years: 66.0% - (8 of 12 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Adderall 30:
  • female: 67.0% - (36 of 53 people)
  • male: 71.0% - (15 of 21 people)
Lithium Carbonate:
  • female: 39.0% - (20 of 51 people)
  • male: 55.0% - (11 of 20 people)

Drug effectiveness by age:

Adderall 30:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 60.0% - (3 of 5 people)
  • 20-29: 87.0% - (14 of 16 people)
  • 30-39: 70.0% - (12 of 17 people)
  • 40-49: 56.0% - (13 of 23 people)
  • 50-59: 70.0% - (7 of 10 people)
  • 60+: 66.0% - (2 of 3 people)
Lithium Carbonate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 20.0% - (1 of 5 people)
  • 20-29: 42.0% - (6 of 14 people)
  • 30-39: 44.0% - (8 of 18 people)
  • 40-49: 38.0% - (8 of 21 people)
  • 50-59: 60.0% - (6 of 10 people)
  • 60+: 66.0% - (2 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • tremors
  • weight gain
  • add
  • attention deficit/hyperactivity disorder
  • burping
  • coordination abnormal
  • depression
  • depression aggravated
  • depression suicidal
  • headache
1 - 6 months:
  • adhd
  • anxiety
  • blood pressure increased
  • constipation
  • depressed mood
  • depression suicidal
  • epilepsy
  • goiter
  • libido decreased
  • lightheadedness - dizzy
6 - 12 months:
  • breast pain
  • nipple pain
  • depressed mood
  • depression suicidal
  • double vision
  • fatigue - chronic
  • impulsive behaviour
  • lethargy
  • libido decreased
  • memory impairment
1 - 2 years:
  • abdominal pain diagnosis
  • burning feet syndrome
  • ibs
  • joint instability
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness
  • muscle aches
  • skin discoloration - bluish
  • lack of strength, muscle weakness, weakness
  • diarrhea
  • haemorrhagic ovarian cyst
2 - 5 years:
  • breast pain
  • injury
  • diarrhea
  • haemorrhagic ovarian cyst
  • hepatic adenoma
  • memory impairment
  • nipple pain
  • avoidant personality disorder
  • bone pain
  • cholecystitis chronic
5 - 10 years:
  • burning feet syndrome
  • ibs
  • joint instability
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness
  • muscle aches
  • skin discoloration - bluish
  • burping
  • fatigue - chronic
  • heart rate abnormal
  • abdominal pain diagnosis
10+ years:
  • lack of strength, muscle weakness, weakness
  • dizziness
  • frequent headaches
  • heat rash
  • sweating increased
  • abdomen - swollen
  • gerd
  • movement - uncontrollable
  • tardive dyskinesia
not specified:
  • insomnia
  • depression
  • fatigue
  • nausea
  • suicidal ideation
  • mania
  • tremor
  • anxiety
  • neuropathy peripheral
  • aggression

Most common drug interactions by gender *:

female:
  • insomnia
  • abdominal pain diagnosis
  • burning feet syndrome
  • ibs
  • joint instability
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness
  • muscle aches
  • skin discoloration - bluish
  • depression
  • tardive dyskinesia
male:
  • insomnia
  • tremor
  • abnormal behaviour
  • aggression
  • depression
  • fatigue
  • nausea
  • neuropathy peripheral
  • pain in extremity
  • psychotic disorder

Most common drug interactions by age *:

2-9:
  • confusional state
  • dystonia
  • extrapyramidal disorder
  • fear
  • neuroleptic malignant syndrome
10-19:
  • pyrexia
  • mania
  • suicide attempt
  • sweating - excessive
  • weight increased
  • hepatic failure
  • aggression
  • agitation
  • electrocardiogram qt prolonged
  • sedation
20-29:
  • breast pain
  • nipple pain
  • drug toxicity
  • fatigue
  • insomnia
  • joint injury
  • prescribed overdose
  • suicidal ideation
  • headache
  • loose associations
30-39:
  • abdominal pain diagnosis
  • burning feet syndrome
  • ibs
  • joint instability
  • loss of sensation, numbness and tingling, paresthesias, sensory loss, tingling and numbness
  • muscle aches
  • skin discoloration - bluish
  • depression
  • diarrhea
  • haemorrhagic ovarian cyst
40-49:
  • diabetes mellitus
  • abnormal behaviour
  • aggression
  • delusion
  • diabetes mellitus inadequate control
  • diabetic neuropathy
  • gastrooesophageal reflux disease
  • hallucination
  • insomnia
  • psychotic disorder
50-59:
  • injury
  • insomnia
  • abnormal behaviour
  • aggression
  • bipolar disorder
  • delusion
  • dyskinesia
  • emotional distress
  • fungal infection
  • gastrooesophageal reflux disease
60+:
  • clostridial infection
  • depression
  • hyperhidrosis
  • insomnia
  • lack of strength, muscle weakness, weakness
  • loss of consciousness
  • nausea
  • rash generalised
  • suicidal ideation
  • thirst

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Adderall 30 and Lithium carbonate?

Can you answer these questions?

More questions for: Adderall 30, Lithium carbonate

You may be interested in these reviews

More reviews for: Adderall 30, Lithium carbonate

On eHealthMe, Adderall 30 (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is often used to treat attention deficit hyperactivity disorder. Lithium carbonate (lithium carbonate) is often used to treat bipolar disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.